International Severe Asthma Registry Mission Statement

被引:45
作者
Canonica, G. Walter [1 ,2 ]
Alacqua, Marianna [3 ]
Altraja, Alan [4 ,5 ]
Backer, Vibeke [6 ,7 ]
Bel, Elisabeth [8 ]
Bjermer, Leif [9 ]
Bjornsdottir, Unnur [10 ]
Bourdin, Arnaud [11 ]
Brusselle, Guy G. [12 ,13 ]
Christoff, George C. [14 ]
Cosio, Borja G. [15 ]
Costello, Richard W. [16 ,17 ]
FitzGerald, J. Mark [18 ]
Gibson, Peter G. [19 ,20 ]
Heaney, Liam G. [21 ]
Heffler, Enrico [1 ,2 ]
Hew, Mark [22 ]
Iwanaga, Takashi [23 ]
Jones, Rupert C. [24 ]
Siyue, Mariko Koh [25 ,26 ]
Rhee, Chin Kook [27 ]
Lehmann, Sverre [28 ]
Lehtimaki, Lauri A. [29 ,30 ]
Ludviksdottir, Dora [31 ,32 ]
Maitland-van der Zee, Anke-Hilse [33 ]
Menzies-Gow, Andrew N. [34 ]
Papadopoulos, Nikolaos G. [35 ,36 ]
Plaza, Vicente [37 ,38 ,39 ]
Perez de Llano, Luis [40 ]
Peters, Matthew [41 ]
Porsbjerg, Celeste M. [42 ]
Sadatsafavi, Mohsen [43 ]
Cho, You Sook [44 ]
Tohda, Yuji [23 ]
Tran, Trung N. [45 ]
Wang, Eileen [46 ,47 ]
Zangrilli, James [45 ]
Bulathsinhala, Lakmini [48 ]
Carter, Victoria A. [48 ]
Chaudhry, Isha [48 ]
Eleangovan, Neva [48 ]
Hosseini, Naeimeh [48 ]
Le, Thao L. [48 ]
Murray, Ruth B. [48 ]
Price, Chris A. [48 ]
Price, David B. [48 ,49 ,50 ]
机构
[1] Humanitas Univ & Res Hosp, Personalized Med Asthma & Allergy Clin, Milan, Italy
[2] SANI, Milan, Italy
[3] AstraZeneca, Cambridge, England
[4] Univ Tartu, Dept Pulm Med, Tartu, Estonia
[5] Tartu Univ Hosp, Dept Pulm Med, Tartu, Estonia
[6] Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark
[7] Univ Copenhagen, Copenhagen, Denmark
[8] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Amsterdam, Netherlands
[9] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Resp Med & Allergol, Lund, Sweden
[10] Natl Univ Hosp Iceland, Landspitali, Dept Resp Med & Sleep, Reykjavik, Iceland
[11] Arnaud Villeneuve Hosp, Montpellier Univ Hosp, Dept Resp Dis, Montpellier, France
[12] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium
[13] Erasmus MC, Dept Epidemiol & Resp Med, Ghent, Belgium
[14] Med Univ Sofia, Fac Publ Hlth, Sofia, Bulgaria
[15] Son Espases Univ Hosp IdISBa Ciberes, Mallorca, Spain
[16] Beaumont Hosp, Clin Res Ctr, Smurfit Bldg, Dublin, Ireland
[17] RCSI, Dept Resp Med, Dublin, Ireland
[18] Inst Heart Lung Hlth, Vancouver, BC, Canada
[19] Univ Newcastle, Prior Res Ctr Hlth Lungs, Australasian Severe Asthma Network, Newcastle, NSW, Australia
[20] John Hunter Hosp, Dept Resp & Sleep Med, Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[21] Queens Univ Belfast, UK Severe Asthma Network & Natl Registry, Belfast, Antrim, North Ireland
[22] Alfred Hlth, Allergy Asthma & Clin Immunol Serv, Melbourne, Vic, Australia
[23] Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osakasayama, Japan
[24] Univ Plymouth, Fac Med & Dent, Plymouth, Devon, England
[25] Singapore Gen Hosp, Resp & Crit Care Med, Singapore, Singapore
[26] SingHlth Duke NUS Lung Ctr, Singapore, Singapore
[27] Catholic Univ Korea, St Marys Hosp, Coll Med, Div Pulm Allergy & Crit Care Med,Dept Internal Me, Seoul, South Korea
[28] Univ Bergen, Dept Clin Sci, Sect Thorac Med, Bergen, Norway
[29] Tampere Univ Hosp, Allergy Ctr, Tampere, Finland
[30] Univ Tampere, Tampere, Finland
[31] Landspitali Univ Hosp, Dept Resp Med, Reykjavik, Iceland
[32] Univ Iceland, Reykjavik, Iceland
[33] Univ Amsterdam, Dept Resp Med, Amsterdam UMC, Amsterdam, Netherlands
[34] Royal Brompton & Harefield NHS Fdn Trust, UK Severe Asthma Network, London, England
[35] Univ Manchester, Resp Med, Manchester, Lancs, England
[36] Univ Athens, Pediat Clin 2, Allergy Dept, Athens, Greece
[37] Hosp Santa Creu & Sant Pau, Dept Resp Med, Barcelona, Spain
[38] IIB St Pau, Barcelona, Spain
[39] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[40] Hosp Univ Lucus Augusti, Dept Resp Med, Lugo, Spain
[41] Concord Hosp, Dept Thorac Med, Sydney, NSW, Australia
[42] Bispebjerg Hosp, Resp Res Unit, Copenhagen, Denmark
[43] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[44] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Allergy & Clin Immunol,Coll Med, Seoul, South Korea
[45] AstraZeneca, Gaithersburg, MD USA
[46] Natl Jewish Hlth, Div Allergy & Clin Immunol, Dept Med, Denver, CO USA
[47] Univ Colorado Hosp, Dept Internal Med, Div Allergy & Clin Immunol, Aurora, CO USA
[48] Optimum Patient Care, Cambridge, England
[49] Observat & Pragmat Res Inst, Singapore, Singapore
[50] Univ Aberdeen, Acad Primary Care, Aberdeen, Scotland
关键词
ISAR; severe asthma; PREVALENCE; DEFINITION; OMALIZUMAB; PHENOTYPES; ADULTS; COSTS;
D O I
10.1016/j.chest.2019.10.051
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Regional and/or national severe asthma registries provide valuable country-specific information. However, they are often limited in scope within the broader definitions of severe asthma, have insufficient statistical power to answer many research questions, lack intraoperability to share lessons learned, and have fundamental differences in data collected, making cross comparisons difficult. What is missing is a worldwide registry which brings all severe asthma data together in a cohesive way, under a single umbrella, based on standardized data collection protocols, permitting data to be shared seamlessly. The International Severe Asthma Registry (ISAR; http://isaregistries.org/) is the first global adult severe asthma registry. It is a joint initiative where national registries (both newly created and preexisting) retain ownership of their own data but open their borders and share data with ISAR for ethically approved research purposes. Its strength comes from collection of patient-level, anonymous, longitudinal, real-life, standardized, high-quality data (using a core set of variables) from countries across the world, combined with organizational structure, database experience, inclusivity/openness, and clinical, academic, and database expertise. This gives ISAR sufficient statistical power to answer important research questions, sufficient data standardization to compare across countries and regions, and the structure and expertise necessary to ensure its continuance and the scientific integrity and clinical applicability of its research. ISAR offers a unique opportunity to implement existing knowledge, generate new knowledge, and identify the unknown, therefore promoting new research. The aim of this commentary is to fully describe how ISAR may improve our understanding of severe asthma.
引用
收藏
页码:805 / 814
页数:10
相关论文
共 35 条
  • [1] [Anonymous], [No title captured]
  • [2] Managing asthma in the era of biological therapies
    Bardin, Philip G.
    Price, David
    Chanez, Pascal
    Humbert, Marc
    Bourdin, Arnaud
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (05) : 376 - 378
  • [3] Clinical phenotypes of asthma
    Bel, EH
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (01) : 44 - 50
  • [4] Disaggregating asthma: Big investigation versus big data
    Belgrave, Danielle
    Henderson, John
    Simpson, Angela
    Buchan, Iain
    Bishop, Christopher
    Custovic, Adnan
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : 400 - 407
  • [5] Mortality: a neglected outcome in OCS-treated severe asthma
    Bourdin, Arnaud
    Molinari, Nicolas
    Vachier, Isabelle
    Pahus, Laurie
    Suehs, Carey
    Chanez, Pascal
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (05)
  • [6] Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
    Bousquet, Jean
    Mantzouranis, Eva
    Cruz, Alvaro A.
    Ait-Khaled, Nadia
    Baena-Cagnani, Carlos E.
    Bleecker, Eugene R.
    Brightling, Chris E.
    Burney, Peter
    Bush, Andrew
    Busse, William W.
    Casale, Thomas B.
    Chan-Yeung, Moira
    Chen, Rongchang
    Chowdhury, Badrul
    Chung, Kian Fan
    Dahl, Ronald
    Drazen, Jeffrey M.
    Fabbri, Leonardo M.
    Holgate, Stephen T.
    Kauffmann, Francine
    Haahtela, Tari
    Khaltaev, Nikolai
    Kiley, James P.
    Masjedi, Mohammad R.
    Mohammad, Yousser
    O'Byrne, Paul
    Partridge, Martyn R.
    Rabe, Klaus F.
    Togias, Alkis
    van Weel, Christiaan
    Wenzel, Sally
    Zhong, Nanshan
    Zuberbier, Torsten
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (05) : 926 - 938
  • [7] Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study
    Bulathsinhala, Lakmini
    Eleangovan, Nevaashni
    Heaney, Liam G.
    Menzies-Gow, Andrew
    Gibson, Peter G.
    Peters, Matthew
    Hew, Mark
    van Boven, Job F. M.
    Lehtimaki, Lauri
    van Ganse, Eric
    Belhassen, Manon
    Harvey, Erin S.
    Perez de Llano, Luis
    Maitland-van der Zee, Anke H.
    Papadopoulos, Nikolaos G.
    Fitzgerald, J. Mark
    Porsbjerg, Celeste
    Canonica, G. Walter
    Backer, Vibeke
    Rhee, Chin Kook
    Verhamme, Katia M. C.
    Buhl, Roland
    Cosio, Borja G.
    Carter, Victoria
    Price, Chris
    Le, Thao
    d'Alcontres, Martina Stagno
    Gopalan, Gokul
    Tran, Trung N.
    Price, David
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (02) : 578 - +
  • [8] Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033
  • [9] Severe asthma in adults: What are the important questions?
    Chanez, Pascal
    Wenzel, Sally E.
    Anderson, Gary P.
    Anto, Josep M.
    Bel, Elisabeth H.
    Boulet, Louis-Philippe
    Brightling, Christopher E.
    Busse, William W.
    Castro, Mario
    Dahlen, Babro
    Dahlen, Sven Erik
    Fabbri, Leo M.
    Holgate, Stephen T.
    Humbert, Marc
    Gaga, Mina
    Joos, Guy F.
    Levy, Bruce
    Rabe, Klaus F.
    Sterk, Peter J.
    Wilson, Susan J.
    Vachier, Isabelle
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (06) : 1337 - 1348
  • [10] Chastek Benjamin, 2016, J Manag Care Spec Pharm, V22, P848, DOI 10.18553/jmcp.2016.22.7.848